| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 9.998 | 5.158 | 9.090 | 4.185 | 11.863 | 25.360 | 15.283 |
| Total Income - EUR | - | - | - | 9.998 | 5.158 | 9.090 | 4.185 | 11.863 | 25.360 | 15.283 |
| Total Expenses - EUR | - | - | - | 8.435 | 1.722 | 3.865 | 1.072 | 9.777 | 9.252 | 9.341 |
| Gross Profit/Loss - EUR | - | - | - | 1.563 | 3.436 | 5.225 | 3.113 | 2.086 | 16.108 | 5.943 |
| Net Profit/Loss - EUR | - | - | - | 1.263 | 3.281 | 5.048 | 3.000 | 1.973 | 15.867 | 5.034 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Diamed Proconsult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 1.587 | 4.932 | 9.858 | 12.412 | 15.426 | 31.310 | 21.860 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 425 | 1.598 | 5.891 | 5.776 | 5.605 | 6.778 | 4.511 |
| Cash | - | - | - | 1.162 | 3.334 | 3.968 | 6.636 | 9.821 | 24.532 | 17.349 |
| Shareholders Funds | - | - | - | 1.306 | 4.562 | 9.523 | 12.311 | 14.322 | 30.146 | 19.822 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 281 | 371 | 336 | 101 | 1.103 | 1.164 | 2.038 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Diamed Proconsult S.r.l.